BUSINESS

GENERAL NEWS

Celltrion sees market share of Remsima rising in European nations

SEOUL, Celltrion Inc. saw the combined market share of its autoimmune biosimilar infliximab products, Remsima and Remsima SC, rising in five European nations, company officials said Tuesday.

The combined market share of Remsima and the subcutaneous …

(EDITORIAL from Korea Times on April 23)

The Japanese government cannot avoid criticism due to its endorsement of a contentious history textbook that denies the forced conscription of Korean women to serve as sex slaves for Japanese soldiers during World War II. The textbook, infamous for